Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET-PA) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Metlife (MET-PA) over the last 17 years, with Q3 2025 value amounting to $48.5 billion.

  • Metlife's Other Non-Current Liabilities rose 2696.4% to $48.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $48.5 billion, marking a year-over-year increase of 2696.4%. This contributed to the annual value of $36.8 billion for FY2024, which is 289.9% up from last year.
  • Per Metlife's latest filing, its Other Non-Current Liabilities stood at $48.5 billion for Q3 2025, which was up 2696.4% from $39.1 billion recorded in Q2 2025.
  • In the past 5 years, Metlife's Other Non-Current Liabilities registered a high of $48.5 billion during Q3 2025, and its lowest value of $22.5 billion during Q4 2021.
  • Its 5-year average for Other Non-Current Liabilities is $31.7 billion, with a median of $34.6 billion in 2023.
  • As far as peak fluctuations go, Metlife's Other Non-Current Liabilities plummeted by 1129.13% in 2021, and later soared by 4398.69% in 2024.
  • Over the past 5 years, Metlife's Other Non-Current Liabilities (Quarter) stood at $22.5 billion in 2021, then grew by 15.06% to $25.9 billion in 2022, then skyrocketed by 38.07% to $35.8 billion in 2023, then increased by 2.9% to $36.8 billion in 2024, then soared by 31.51% to $48.5 billion in 2025.
  • Its Other Non-Current Liabilities was $48.5 billion in Q3 2025, compared to $39.1 billion in Q2 2025 and $38.8 billion in Q1 2025.